Company / CapEx per Share
IONIS PHARMACEUTICALS INC CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.33
FY2025
5-year range
$0.11 / $0.33
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#35 of 192
Health Care
What the data says
IONIS PHARMACEUTICALS INC's capex per share of $0.33 is higher than 82% of companies in the Health Care sector (FY2025). CapEx per Share has increased for 3 consecutive years, from $0.11 in FY2022 to $0.33 in FY2025.
Based on SEC 10-K filings.
0.33 in FY2025 with a 5-year CAGR of +27.4%. Top quartile in the Health Care sector.
Improved from $0.17 to $0.33 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +43.0%
- 5-Year CAGR
- +27.4%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 192This company $0.33 Sector average $2.46
▼
-86.8% below sector average
Key checks
Key Insights
- IONIS PHARMACEUTICALS INC's capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 3.9% year-over-year.
- Ranks #35 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.33 | +3.9% |
| FY2024 | $0.31 | +87.2% |
| FY2023 | $0.17 | +50.5% |
| FY2022 | $0.11 | -49.4% |
| FY2021 | $0.22 | +127.1% |
| FY2020 | $0.10 | -61.5% |
| FY2019 | $0.25 | +343.2% |
| FY2018 | $0.06 | -80.1% |
| FY2017 | $0.29 | +384.0% |
| FY2016 | $0.06 | -9.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026